Concussions in Ice Hockey — Moving Toward Objective Diagnoses and Point-of-care Treatment: A Review
- 1 September 2020
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Optometry and Vision Science
- Vol. 19 (9), 380-386
- https://doi.org/10.1249/jsr.0000000000000752
Abstract
The incidence of sport-related concussion coupled with a doubling of the participation rate in youth hockey over the past two decades provides impetus for the review of the most promising concussion treatment options. This narrative review summarizes the future treatment options for sport-related concussions in ice hockey, while acknowledging their generalizability to concussion in all sports. Symptom assessment, sign observation, as well as cognitive and balance testing, have historically been used to diagnose a concussion. These methods continue to improve, but the need for effective treatments is clear. Pharmacologic, transcranial light, and nutritional supplement treatment options for concussion warranting further investigation have been identified. Dimethyl fumarate is an immunomodulatory compound thought to trigger antioxidant gene expression. Memantine reduces apoptosis and astrogliosis by inhibiting the calcium influx into cells normally caused by glutamate's activation of N-methyl-d-aspartate receptors. Thioredoxin-mimetic peptides and transcranial photobiomodulation temper the effects of the energy crisis by acting as free radical scavengers. In addition, seven neuroprotective nutritional supplements have been identified: berberine, creatine, curcumin, melatonin, omega-3 fatty acids, resveratrol, and vitamins. An estimated US $1.1 billion has been spent on unsuccessful traumatic brain injury clinical trials. As our ability to accurately diagnose concussion improves, dimethyl fumarate, memantine, thioredoxin-mimetic peptides, transcranial photobiomodulation, and nutritional supplements (berberine, creatine, curcumin, melatonin, omega-3 fatty acids, resveratrol, and vitamins) warrant further preclinical and clinical examination in advancing the treatment of sport-related concussions.This publication has 64 references indexed in Scilit:
- Therapy Development for Diffuse Axonal InjuryJournal of Neurotrauma, 2013
- Amelioration of Acute Sequelae of Blast Induced Mild Traumatic Brain Injury by N-Acetyl Cysteine: A Double-Blind, Placebo Controlled StudyPLOS ONE, 2013
- The immunology of traumatic brain injury: a prime target for Alzheimer’s disease preventionJournal of Neuroinflammation, 2012
- Low‐Level Laser Therapy for Closed‐Head Traumatic Brain Injury in Mice: Effect of Different WavelengthsLasers in Surgery and Medicine, 2012
- A mouse model of human repetitive mild traumatic brain injuryJournal of Neuroscience Methods, 2012
- The Salutary Effects of DHA Dietary Supplementation on Cognition, Neuroplasticity, and Membrane Homeostasis after Brain TraumaJournal of Neurotrauma, 2011
- Concussion in youth ice hockey: It's time to break the cycleCMAJ : Canadian Medical Association Journal, 2011
- A prospective study of concussions among National Hockey League players during regular season games: the NHL-NHLPA Concussion ProgramCMAJ : Canadian Medical Association Journal, 2011
- Diffuse Brain Injury Elevates Tonic Glutamate Levels and Potassium-Evoked Glutamate Release in Discrete Brain Regions at Two Days Post-Injury: An Enzyme-Based Microelectrode Array StudyJournal of Neurotrauma, 2010
- SECOND-IMPACT SYNDROMEClinics in Sports Medicine, 1998